Mebias Discovery

Developer of GPCR drugs for the non-opioid treatment of pain

placePhiladelphia, Pennsylvania, United States calendar_todayFounded 2015 groups5 employees language mebiasdiscovery.com

Innovation

3 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 143 times.

YearFilings
20182
20192
20202
20212
20222
20242
20251

Investor mix

5 investors on record; lead investors include Viva Biotech.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%
Coming soon